Timber Pharmaceuticals (TMBR) News Today → Trump’s Gift Could Unleash $51 Billion in New Wealth (From Wealthpin Pro) (Ad) Free TMBR Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 13, 2024 | reuters.comCan timber construction overcome its growing pains?March 10, 2024 | businesswire.comTimber Pharmaceuticals, Inc., a LEO Pharma Company, Presents Late-Breaking Preliminary Results of TMB-001 in Moderate-to-Severe Congenital Ichthyosis (CI) at the 2024 AAD Annual MeetingJanuary 28, 2024 | msn.comTimber Pharmaceuticals Announces Official Name ChangeJanuary 13, 2024 | uk.investing.comTimber Pharmaceuticals Inc (TMBRQ)November 29, 2023 | finance.yahoo.comTimber Pharmaceuticals Announces Commencement of NYSE American Delisting Proceedings: Common Stock Expected to Begin Trading on the OTC MarketNovember 29, 2023 | finance.yahoo.comNYSE American to Suspend Trading Immediately in Timber Pharmaceuticals, Inc. (TMBR)November 28, 2023 | tmcnet.comTimber Pharmaceuticals Receives Court Approval of All "First Day" Motions to Support Business Operations & Discloses Communication From NYSE AmericanNovember 28, 2023 | finance.yahoo.comTimber Pharmaceuticals Receives Court Approval of All “First Day” Motions to Support Business Operations & Discloses Communication From NYSE AmericanNovember 21, 2023 | seekingalpha.comMVST, FBIO and VTVT among mid-day moversNovember 17, 2023 | msn.comTimber Pharmaceuticals files for Chapter 11 in wake of failed mergerNovember 16, 2023 | msn.comTimber Pharma slips ahead of shareholder vote on mergerSeptember 18, 2023 | finance.yahoo.comTimber Pharmaceuticals Announces NYSE Acceptance of Plan to Regain Listing ComplianceAugust 29, 2023 | 247wallst.comHC Wainwright Downgrades Timber PharmaceuticalsAugust 28, 2023 | msn.comHC Wainwright & Co. Downgrades Timber Pharmaceuticals (TMBR)August 21, 2023 | benzinga.comTMBR Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Timber Pharmaceuticals, Inc. Is Fair to ShareholdersAugust 21, 2023 | markets.businessinsider.comDow Tumbles Over 100 Points; Timber Pharmaceuticals Shares Spike HigherAugust 21, 2023 | msn.comTimber to be taken private by LEO Pharma, stock soars 100%August 21, 2023 | investorplace.comWhy Is Timber Pharmaceuticals (TMBR) Stock Up 96% Today?August 21, 2023 | markets.businessinsider.comUS Stocks Mostly Higher; Nasdaq Jumps 100 PointsAugust 21, 2023 | marketwatch.comTimber Pharmaceuticals Shares Soar on Takeover by LEO PharmaAugust 21, 2023 | benzinga.comWhy Timber Pharmaceuticals Stock Is Skyrocketing TodayAugust 21, 2023 | finance.yahoo.comLEO Pharma Signs Agreement to Acquire Timber PharmaceuticalsAugust 21, 2023 | finance.yahoo.comTimber Pharmaceuticals to be Acquired by LEO PharmaAugust 15, 2023 | morningstar.comTimber Pharmaceuticals Inc Ordinary SharesJuly 3, 2023 | finance.yahoo.comTimber Pharmaceuticals Discloses Communication From NYSE AmericanJune 5, 2023 | msn.comTimber Pharmaceuticals Soars as FDA Removes HurdleJune 5, 2023 | msn.comTimber Pharmaceuticals stock jumps as much as 83% after FDA waiver to forgo rodent studyJune 5, 2023 | finance.yahoo.comTimber Pharmaceuticals Announces FDA Grant of CARC Waiver for TMB-001May 15, 2023 | finance.yahoo.comTimber Pharmaceuticals Provides Business Update and Announces First Quarter 2023 Financial ResultsApril 14, 2023 | finance.yahoo.comBears are Losing Control Over Timber Pharmaceuticals, Inc. (TMBR), Here's Why It's a 'Buy' NowApril 11, 2023 | msn.comHC Wainwright & Co. Reiterates Timber Pharmaceuticals (TMBR) Buy RecommendationMarch 31, 2023 | finance.yahoo.comTimber Pharmaceuticals Provides Business Update and Announces Fourth Quarter and Year End 2022 Financial ResultsMarch 20, 2023 | finance.yahoo.comTimber Pharmaceuticals Announces Publication of Sub-Analysis of Phase 2b CONTROL study in Clinical and Experimental DermatologyFebruary 24, 2023 | finance.yahoo.comTimber Pharmaceuticals Receives European Orphan Drug Designation for TMB-001 in X-Linked Recessive IchthyosisFebruary 24, 2023 | investorplace.comWhy Is Timber Pharmaceuticals (TMBR) Stock Up 61% Today?February 20, 2023 | uk.finance.yahoo.comTimber Pharmaceuticals, Inc. (TMBR)December 14, 2022 | finance.yahoo.comTimber Pharmaceuticals to Host Investor Business Briefing: Milestone Achievements and Forward OutlookDecember 9, 2022 | finance.yahoo.comTimber Pharmaceuticals Regains Compliance with NYSE American Continued Listing StandardsNovember 14, 2022 | finance.yahoo.comTimber Pharmaceuticals Provides Business Update and Announces Third Quarter 2022 Financial ResultsNovember 9, 2022 | msn.comWhy RumbleON Shares Are Trading Higher By Around 28%? Here Are 84 Stocks Moving In Wednesday's Mid-Day SessionNovember 8, 2022 | finance.yahoo.comTimber Pharmaceuticals, Inc. Announces 1-for-50 Reverse Stock SplitNovember 3, 2022 | finance.yahoo.comTimber Pharmaceuticals Announces Halt of Common Stock TradingOctober 25, 2022 | finance.yahoo.comTimber Pharmaceuticals Receives European Orphan Designation for Autosomal Recessive Congenital Ichthyosis & Positive Comments on Pediatric Investigation Plan for TMB-001 in Autosomal Recessive CI & X-Linked Recessive IchthyosisOctober 3, 2022 | msn.com1TMBR : Why Timber Pharmaceuticals Shares Are Getting HammeredOctober 3, 2022 | finance.yahoo.comTimber Pharmaceuticals Announces $1.3 Million Registered Direct OfferingSeptember 14, 2022 | finance.yahoo.comTimber Pharmaceuticals Receives Positive Opinion on Orphan Designation from European Medicines Agency for TMB-001 for Treatment of Autosomal Recessive Congenital IchthyosisAugust 29, 2022 | finance.yahoo.comTimber Pharmaceuticals Announces Notification of NYSE American Continued Listing DeficiencyAugust 29, 2022 | finance.yahoo.comTimber Pharmaceuticals to Highlight Phase 2b CONTROL Study Results in Multiple Presentations at 31st EADV CongressAugust 26, 2022 | finance.yahoo.comTimber Pharmaceuticals Announces Publication of Results from Phase 2b CONTROL Study of FDA-Designated Breakthrough Therapy TMB-001 in the Journal of the American Academy of DermatologyAugust 11, 2022 | finance.yahoo.comTimber Pharmaceuticals Provides Business Update and Announces Second Quarter 2022 Financial Results Get Timber Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for TMBR and its competitors with MarketBeat's FREE daily newsletter. Email Address Elon Musk’s Final Masterpiece: “X-9840” (Ad)The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just released the details on what he’s calling Elon’s Project X-9840. Click here to see the details because there’s not much time to prepare. TMBR Media Mentions By Week TMBR Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TMBR News Sentiment▼0.000.67▲Average Medical News Sentiment TMBR News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TMBR Articles This Week▼00▲TMBR Articles Average Week Get Timber Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for TMBR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Processa Pharmaceuticals News Today Exicure News Today Onconetix News Today Artelo Biosciences News Today Ensysce Biosciences News Today China Pharma News Today Kazia Therapeutics News Today Cingulate News Today Evoke Pharma News Today Virios Therapeutics News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:TMBR) was last updated on 6/5/2024 by MarketBeat.com Staff From Our PartnersElon Musk’s Final Masterpiece: “X-9840”The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Ju...Paradigm Press | SponsoredWas the Great Financial Crisis fun?The Great Financial Crisis, which actually started in the summer of 2007 and did not end until March of 2009, ...Brooks Enterprises | Sponsored[Webinar] Understanding Covered CallsDiscover the details of this option-selling strategy.OIC | SponsoredWhat’s Pelosi Buying Now?They Make the Top Investors Look Like Amateurs They beat the market for three years straight… avoided some ...Altimetry | SponsoredBiden Nomination CANCELED?The Hill just published that Joe Biden has received enough delegates to…“clinch the Democratic presidential no...The Freeport Society | SponsoredClaim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an eff...Crypto Swap Profits | SponsoredAre You Positioned For The New Energy Goldrush?Open AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Nvidia’s CEO calls it the “next amazing revolution” … and even declared it “is going to be flat out of the big...Banyan Hill Publishing | Sponsored